Filter News
Area of Research
- (-) Neutron Science (5)
- Advanced Manufacturing (1)
- Biology and Environment (17)
- Clean Energy (15)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (15)
- Materials (11)
- Materials for Computing (2)
- National Security (15)
- Nuclear Science and Technology (5)
- Quantum information Science (1)
- Supercomputing (12)
News Topics
- (-) Biomedical (4)
- (-) Cybersecurity (1)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Computer Science (6)
- Coronavirus (5)
- Decarbonization (1)
- Energy Storage (2)
- Environment (3)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (13)
- Microscopy (1)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (45)
- Nuclear Energy (1)
- Physics (7)
- Quantum Science (4)
- Security (1)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (2)
- Transportation (3)
Media Contacts
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.